Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATAPRES: Clonidine for Delirium in Ventilated ICU Patients
NCT01876355Phase 3Unknown
- Sponsor
- Deventer Ziekenhuis
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in delirium, sponsored by Deventer Ziekenhuis. Status: unknown.
02
Drugs
clonidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT01876355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876355.